PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.54%
Revenue growth at 75-90% of IXX.DE's 26.71%. Bill Ackman would push for innovation or market expansion to catch up.
18.42%
Gross profit growth at 50-75% of IXX.DE's 35.00%. Martin Whitman would question if cost structure or brand is lagging.
3.61%
EBIT growth below 50% of IXX.DE's 358.37%. Michael Burry would suspect deeper competitive or cost structure issues.
11.38%
Operating income growth under 50% of IXX.DE's 358.37%. Michael Burry would be concerned about deeper cost or sales issues.
15.82%
Net income growth under 50% of IXX.DE's 211.47%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.67%
EPS growth under 50% of IXX.DE's 201.08%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
16.67%
Diluted EPS growth under 50% of IXX.DE's 201.08%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1640.45%
Dividend growth of 1640.45% while IXX.DE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-60.91%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-62.05%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
209.09%
10Y revenue/share CAGR above 1.5x IXX.DE's 101.78%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
88.60%
5Y revenue/share CAGR above 1.5x IXX.DE's 47.28%. David Dodd would look for consistent product or market expansions fueling outperformance.
86.60%
3Y revenue/share CAGR above 1.5x IXX.DE's 8.87%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
-22.10%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
83.73%
Positive 3Y OCF/share CAGR while IXX.DE is negative. John Neff might see a big short-term edge in operational efficiency.
878.42%
Positive 10Y CAGR while IXX.DE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
108.66%
5Y net income/share CAGR above 1.5x IXX.DE's 10.29%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
413.81%
Positive short-term CAGR while IXX.DE is negative. John Neff would see a clear advantage in near-term profit trajectory.
242.42%
10Y equity/share CAGR above 1.5x IXX.DE's 87.93%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
142.47%
5Y equity/share CAGR above 1.5x IXX.DE's 37.88%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
50.13%
3Y equity/share CAGR above 1.5x IXX.DE's 26.30%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.99%
Below 50% of IXX.DE's 358.32%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
40.31%
AR growth well above IXX.DE's 18.88%. Michael Burry fears inflated revenue or higher default risk in the near future.
27.84%
Inventory growth well above IXX.DE's 2.37%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
15.32%
Asset growth above 1.5x IXX.DE's 2.75%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.67%
Positive BV/share change while IXX.DE is negative. John Neff sees a clear edge over a competitor losing equity.
15.98%
Debt growth far above IXX.DE's 15.97%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
29.03%
SG&A growth well above IXX.DE's 10.63%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.